sleep monitoring

Digital

As of 2024, more than one-third of American adults don't get enough sleep, and sleep satisfaction levels are worryingly low.

News

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.